Sometimes the only way to express your regret for missed opportunities is in the form of bitterness. In this case the bitterness is in the form of sour grapes as described in Aesop's Fables. Today's regrettable missed opportunity is Pharmaceutical Product Development (PPDI). At the close, PPDI was up by 8.18% at a time when the Dow Industrials had fallen by 1.90%.
On July 23, 2009, I bought Pharmaceutical Product Development (PPDI) at $19.26. I was at my smuggest when I sold the stock for a 9.78% gain in less than 2 weeks. Suffice to say, had I held on to PPDI from July 2009 until today I would have a 43.5% gain on my hands. On our February 13, 2010 Nasdaq 100 Watch List, we reiterated looking into PPDI since it had fallen within 21% of the new low. February 16th, the first trading day after our watch list came out, happened to be in the lowest quintile for 2010 that you could have bought PPDI. Had anyone followed up on the PPDI recommendation you would have snagged 27.7% in less than 4 months.
Oh well, at least my gain was 260% on an annualized basis as opposed to the annualized gain of 110% since February 2010. Who needs a stock that goes up 8% when the rest of the market is cratering anyway.
-Touc
Email our team here.